Influenza vaccination in cancer patients undergoing systemic therapy

Clinical Medicine Insights: Oncology

Volumn 8, Issue , 2014, Pages 57-64

  Shehata, Mahmoud A ^a   Karim, Nagla Abdel ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer patients; Chemotherapy; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG SAFETY; FEVER; FLU LIKE SYNDROME; GEOMETRIC MEAN TITER; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK PATIENT; HUMAN; IMMUNOLOGICAL PARAMETERS; INFLUENZA; INFLUENZA VACCINATION; LOCAL SKIN REACTION; LOW GRADE FEVER; MORBIDITY; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PROGRAM EFFICACY; SEROLOGY; SOLID TUMOR; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TUMOR IMMUNITY; VIRUS IMMUNITY;

EID: 84899765706     PISSN: None     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.Ss13774     Document Type: Article

References (41)

1. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res. 1971; 31: 420-6.
2. Centers for Disease Control and Prevention Y. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11. MMWR Morb Mortal Wkly Rep. 2010; 59: 989-92.
3. Loulergue P, Mir O, Alexandre J, Ropert S, Goldwasser F, Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol. 2008; 19: 1658.
4. Centers for Disease Control and Prevention X. Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 72-6.
5. Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, Zambon M. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer. 1999; 80: 219-20.
6. Sommer AL, Wachel BK, Smith JA. Evaluation of vaccine dosing in patients with solid tumors receiving myelosuppressive chemotherapy. J Oncol Pharm Pract. 2006; 12: 143-54.
7. Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol. 1975; 102: 553-63.
8. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978; 298: 587-92.
9. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000; 283: 499-505.
10. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986; 76: 761-5.
11. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179-86.
12. Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol. 2010; 28: 2481-90.
13. Novel Swine-Origin Influenza A (H1N1)Virus Investigation Team X. Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360: 2605-15.
14. New influenza A (H1N1) virus: global epidemiological situation, June 2009. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 2009; 84: 249-57.
15. Cooksley CD, Avritscher EB, Bekele BN, Rolston KV, Geraci JM, Elting LS. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer. 2005; 104: 618-28.
16. Steinherz PG, Brown AE, Gross PA, et al. Influenza immunization of children with neoplastic diseases. Cancer. 1980; 45: 750-6.
17. Brydak LB, Guzy J, Starzyk J, Machala M, Gozdz SS. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer. 2001; 9: 65-8.
18. Ganz PA, Shanley JD, Cherry JD. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer. 1978; 42: 2244-7.
19. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007; 56: 1-54.
20. Mazza JJ, Yale SH, Arrowood JR, et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 2005; 3: 214-20.
21. Shildt RA, Luedke DW, Kasai G, El-Beheri S, Laham MN. Antibody response to influenza immunization in adult patients with malignant disease. Cancer. 1979; 44: 1629-35.
22. Robertson JD, Nagesh K, Jowitt SN, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer. 2000; 82: 1261-5.
23. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis. 1993; 12: 778-82.
24. Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol. 2005; 130: 96-8.
25. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000; 284: 1655-63.
26. Mackay HJ, McGee J, Villa D, et al. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment. J Clin Virol. 2011; 50: 212-6.
27. Feery BJ, Sullivan JR, Hurley TH, Evered MG. Immunization with influenza vaccine in patients with haematological malignant disease. Med J Aust. 1977; 1: 292-4.
28. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer. 2005; 45: 831-7.
29. Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL III, Lee JY. Influenza immunization of adult patients with malignant diseases. Ann Intern Med. 1977; 87: 552-7.
30. Brown AE, Steinherz PG, Miller DR, et al. Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis. 1982; 145: 126.
31. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25: 5086-96.
32. Gross PA, Weksler ME, Quinnan GV Jr., Douglas RG Jr., Gaerlan PF, Denning CR. Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol. 1987; 25: 1763-5.
33. Mostow SR, Schoenbaum SC, Dowdle WR, Coleman MT, Kaye HS. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation. Postgrad Med J. 1973; 49: 152-8.
34. Safdar A, Rodriguez MA, Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis. 2006; 194: 1394-7.
35. Schafer AI, Churchill WH, Ames P, Weinstein L. The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer. 1979; 43: 25-30.
36. Ramanathan RK, Potter DM, Belani CP, et al. Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients. J Clin Oncol. 2002; 20: 4313-8.
37. Stiver HG, Weinerman BH. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Can Med Assoc J. 1978; 119: 733,-5, 8.
38. Hodges GR, Davis JW, Lewis HD Jr, et al. Response to influenza A vaccine among high-risk patients. South Med J. 1979; 72: 29-32.
39. Brydak LB, Machala M, Centkowski P, Warzocha K, Bilinski P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine. 2006; 24: 6620-3.
40. Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol. 1994; 91: 115-8.
41. Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF. Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol. 2003; 70: 225-30.